{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:35:00Z","timestamp":1793090100907,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8237318"],"award-info":[{"award-number":["8237318"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105521","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:42:46Z","timestamp":1785912166000},"page":"105521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cascading attrition of in vivo CAR-T therapy: From systemic delivery failure to functional collapse"],"prefix":"10.1016","volume":"227","author":[{"given":"Haipeng","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4903-022X","authenticated-orcid":false,"given":"Jiannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2026.105521_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib2","first-page":"4750","article-title":"High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules","volume":"61","author":"Adams","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105521_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1512494","article-title":"Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products","volume":"16","author":"Alfar","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v17060802","article-title":"Progress in pseudotyping lentiviral vectors towards cell-specific gene delivery in vivo","volume":"17","author":"Arduini","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib5","doi-asserted-by":"crossref","DOI":"10.4110\/in.2026.26.e13","article-title":"From ex vivo to in vivo: advances in lentiviral vector engineering for CAR-T Therapy","volume":"26","author":"Baek","year":"2026","journal-title":"Immune Netw."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105521_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/bloodadvances.2023011992","article-title":"Early predictive factors of failure in autologous CAR T-cell manufacturing and\/or efficacy in hematologic malignancies","volume":"8","author":"Baguet","year":"2024","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105521_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines14020369","article-title":"Challenges and opportunities in lentivirus viral vector manufacturing for in vivo applications","volume":"14","author":"Barbieri","year":"2026","journal-title":"Biomedicines"},{"issue":"140","key":"10.1016\/j.critrevonc.2026.105521_bib8","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0787","article-title":"A model-based analysis of tissue targeting efficacy of nanoparticles","volume":"15","author":"Barua","year":"2018","journal-title":"J. R. Soc. Interface"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s42003-025-07539-5","article-title":"Prevalent integration of genomic repetitive and regulatory elements and donor sequences at CRISPR-Cas9-induced breaks","volume":"8","author":"Bi","year":"2025","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"Vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/bloodadvances.2023011470","article-title":"Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial","volume":"8","author":"Brudno","year":"2024","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"27","key":"10.1016\/j.critrevonc.2026.105521_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202503004","article-title":"Cellular glycocalyx affects nanoparticle access to cell membranes and uptake","volume":"37","author":"Bussin","year":"2025","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib15","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40164-025-00725-5","article-title":"vivo CAR-T cell engineering: concept, research progress, potential challenges and enhancement strategies","volume":"14","author":"Chen","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105521_bib18","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e39","article-title":"RNA metabolism in T lymphocytes","volume":"22","author":"Choi","year":"2022","journal-title":"Immune Netw."},{"issue":"17-18","key":"10.1016\/j.critrevonc.2026.105521_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/hum.2023.119","article-title":"Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors","volume":"34","author":"Costa-Verdera","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.critrevonc.2026.105521_bib20","article-title":"The multifaceted role of SMAD4 in immune cell function","volume":"41","author":"Cui","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.critrevonc.2026.105521_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1742-4690-9-87","article-title":"SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells","volume":"9","author":"Descours","year":"2012","journal-title":"Retrovirology"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymthe.2017.01.011","article-title":"Inducible caspase-9 selectively modulates the toxicities of CD19-specific chimeric antigen receptor-modified T Cells","volume":"25","author":"Diaconu","year":"2017","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105521_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105521_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1502","article-title":"Chimeric antigen receptor T cells in the fast lane among autoimmune disease therapies","volume":"13","author":"Ding","year":"2024","journal-title":"Clin. Transl. Immunol."},{"issue":"7643","key":"10.1016\/j.critrevonc.2026.105521_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"issue":"sup1","key":"10.1016\/j.critrevonc.2026.105521_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.critrevonc.2026.105521_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2026.1720882","article-title":"Rethinking viral vector quantification: a microfluidic approach to standardised functional titre assays","volume":"14","author":"Farcas","year":"2026","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105521_bib28","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1039\/C3SM52860J","article-title":"White blood cell margination in microcirculation","volume":"10","author":"Fedosov","year":"2014","journal-title":"Soft Matter"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105521_bib29","doi-asserted-by":"crossref","DOI":"10.1063\/1.2472479","article-title":"Leukocyte margination in a model microvessel","volume":"19","author":"Freund","year":"2007","journal-title":"Phys. Fluids"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105521_bib30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.cmet.2024.12.007","article-title":"Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy","volume":"37","author":"Frisch","year":"2025","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(23)00631-9","article-title":"FDA investigates risk of secondary lymphomas after CAR-T immunotherapy","volume":"25","author":"Furlow","year":"2024","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066488","article-title":"Diminished Memory T-cell expansion due to delayed kinetics of antigen expression by lentivectors","volume":"8","author":"Furmanov","year":"2013","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40364-026-00899-y","article-title":"vivo engineering of CAR-T cells: delivery strategies and clinical translation","volume":"14","author":"Gao","year":"2026","journal-title":"Biomark. Res."},{"key":"10.1016\/j.critrevonc.2026.105521_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105521_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-021-00842-6","article-title":"Rapid manufacturing of non-activated potent CAR T cells","volume":"6","author":"Ghassemi","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105521_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41591-019-0549-5","article-title":"Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR","volume":"25","author":"Ghorashian","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194631","article-title":"IFN-\u03b3-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapy","volume":"136","author":"Goala","year":"2026","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105521_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202500206","article-title":"Therapeutic implications of biomolecular corona on lipid nanoparticle-based gene delivery systems","volume":"5","author":"Greco","year":"2025","journal-title":"Small Sci."},{"key":"10.1016\/j.critrevonc.2026.105521_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1785592","article-title":"Efficiency and safety of five different agents for in vivo delivery of novel bioengineered RNAi molecules","volume":"13","author":"Guan","year":"2026","journal-title":"Front. Mol. Biosci."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib40","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"51","key":"10.1016\/j.critrevonc.2026.105521_bib41","doi-asserted-by":"crossref","first-page":"34210","DOI":"10.1021\/acs.langmuir.5c03244","article-title":"From single ligand-receptor bond strength to collective avidity: mechanics-guided superselective nanoparticle adhesion to biological membranes","volume":"41","author":"Hamzeh","year":"2025","journal-title":"Langmuir"},{"key":"10.1016\/j.critrevonc.2026.105521_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"45","key":"10.1016\/j.critrevonc.2026.105521_bib43","doi-asserted-by":"crossref","first-page":"15974","DOI":"10.1021\/acs.langmuir.3c01983","article-title":"Adsorption and molecular display of a redox-active protein on gold nanoparticle surfaces","volume":"39","author":"Hoang","year":"2023","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"7571","key":"10.1016\/j.critrevonc.2026.105521_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41392-025-02512-4","article-title":"Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy","volume":"10","author":"Hu","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11684-025-1130-x","article-title":"Tonic signaling in CAR-T therapy: the lever long enough to move the planet","volume":"19","author":"Huang","year":"2025","journal-title":"Front. Med."},{"issue":"6753","key":"10.1016\/j.critrevonc.2026.105521_bib48","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105521_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz1722","article-title":"Biodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion","volume":"12","author":"Jain","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105521_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115597","article-title":"Engineering scFv immunotherapies: From CAR T cells to bispecific antibodies","volume":"166","author":"Jamali","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105521_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/v17081036","article-title":"The era of gene therapy: the advancement of lentiviral vectors and their pseudotyping","volume":"17","author":"Jargalsaikhan","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib53","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/s41467-025-60959-z","article-title":"Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol","volume":"16","author":"Johansson","year":"2025","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105521_bib54","article-title":"Tumor microenvironment immunosuppression: a roadblock to CAR T-cell advancement in solid tumors","volume":"11","author":"Johnson","year":"2022","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105521_bib55","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/bi035802w","article-title":"Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system","volume":"43","author":"Kakudo","year":"2004","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib56","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105521_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/bs.ircmb.2018.10.002","article-title":"Cytosolic Nucleic Acid Sensors in Inflammatory and Autoimmune Disorders","volume":"344","author":"Khan","year":"2019","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105521_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114635","article-title":"Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery","volume":"192","author":"Kim","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"30","key":"10.1016\/j.critrevonc.2026.105521_bib59","doi-asserted-by":"crossref","first-page":"34011","DOI":"10.1021\/acsami.0c05489","article-title":"Development of a microfluidic-based post-treatment process for size-controlled lipid nanoparticles and application to siRNA Delivery","volume":"12","author":"Kimura","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib60","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2013.11.002","article-title":"The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells","volume":"39","author":"Lahaye","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002943","article-title":"Multiomic profiling of chronically activated CD4+ T cells identifies drivers of exhaustion and metabolic reprogramming","volume":"22","author":"Lawton","year":"2024","journal-title":"PLoS. Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105521_bib62","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105521_bib63","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/mt.2012.96","article-title":"Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells","volume":"20","author":"L\u00e9vy","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105521_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coph.2015.08.003","article-title":"Surface engineering of lentiviral vectors for gene transfer into gene therapy target cells","volume":"24","author":"L\u00e9vy","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105521_bib65","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1016\/j.ymthe.2024.07.020","article-title":"Armored bicistronic CAR T cells with dominant-negative TGF-\u03b2 receptor II to overcome resistance in glioblastoma","volume":"32","author":"Li","year":"2024","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116463","article-title":"Metabolic regulation of immunity in the tumor microenvironment","volume":"44","author":"Li","year":"2025","journal-title":"Cell. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006522","article-title":"Metabolic reprogramming via an engineered PGC-1\u03b1 improves human chimeric antigen receptor T-cell therapy against solid tumors","volume":"11","author":"Lontos","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105521_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj6251","article-title":"Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control","volume":"10","author":"Lu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105521_bib69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2018.03.008","article-title":"Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems","volume":"128","author":"Maeki","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/hgtb.2017.086","article-title":"Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines","volume":"28","author":"Manceur","year":"2017","journal-title":"Hum. Gene Ther. Methods"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105521_bib71","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/v5102483","article-title":"Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes","volume":"5","author":"Matreyek","year":"2013","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib72","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41467-020-16248-y","article-title":"Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver","volume":"11","author":"Miao","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006292","article-title":"Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering","volume":"11","author":"Michels","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib74","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1016\/j.ymthe.2025.08.032","article-title":"Orthogonal CRISPR systems for targeted integration and multiplex base editing enable nonviral engineering of allogeneic CAR-T cells","volume":"33","author":"Mikkelsen","year":"2025","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101520","article-title":"Nonclinical strategies and considerations to enable the redosing of gene therapies","volume":"33","author":"Moffit","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.critrevonc.2026.105521_bib76","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jconrel.2022.09.039","article-title":"Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles","volume":"351","author":"Moghimi","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib77","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41467-020-20785-x","article-title":"Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma","volume":"12","author":"Moghimi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105521_bib78","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.omto.2021.01.014","article-title":"HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells","volume":"20","author":"Moore","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.critrevonc.2026.105521_bib79","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/srep04871","article-title":"Margination of micro- and nano-particles in blood flow and its effect on drug delivery","volume":"4","author":"M\u00fcller","year":"2014","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105521_bib80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105521_bib81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/bioengineering11121222","article-title":"Nanoparticle-based drug delivery for vascular applications","volume":"11","author":"Naskar","year":"2024","journal-title":"Bioengineering"},{"issue":"47","key":"10.1016\/j.critrevonc.2026.105521_bib83","doi-asserted-by":"crossref","first-page":"64219","DOI":"10.1021\/acsami.5c17052","article-title":"Effects of Serum Incubation on Lipid Nanoparticle PEG Shedding, mRNA Retention, and Membrane Interactions","volume":"17","author":"Niederkofler","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105521_bib84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI130144","article-title":"CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration","volume":"130","author":"Nobles","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"8110","key":"10.1016\/j.critrevonc.2026.105521_bib85","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-026-10235-x","article-title":"vivo site-specific engineering to reprogram T cells","volume":"652","author":"Nyberg","year":"2026","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib86","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-018-06979-4","article-title":"Cloaking nanoparticles with protein corona shield for targeted drug delivery","volume":"9","author":"Oh","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105521_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251317144","article-title":"Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier","volume":"17","author":"Okuyama","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib88","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105521_bib89","article-title":"Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA-LNP-Based Vaccines","volume":"11","author":"Patel","year":"2023","journal-title":"Vaccin. (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105521_bib90","article-title":"How do nanoparticle properties shape pharmacokinetics and pharmacodynamics? A mechanistic review","volume":"16","author":"Peralta-Cuevas","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105521_bib91","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/bit.28498","article-title":"Insights into product and process related challenges of lentiviral vector bioprocessing","volume":"121","author":"Perry","year":"2024","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105521_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/v13020268","article-title":"Lentiviral Vector Bioprocessing","volume":"13","author":"Perry","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib93","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809158","article-title":"vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib94","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2012.12.029","article-title":"Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format","volume":"166","author":"Phua","year":"2013","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib95","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41420-025-02786-1","article-title":"STING agonists trigger monocyte death via apoptosis, pyroptosis, caspase-8 activation and mitochondrial dysfunction","volume":"11","author":"Pimkova Polidarova","year":"2025","journal-title":"Cell. Death Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12967-024-06052-3","article-title":"From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy","volume":"23","author":"Pinto","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib97","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10529-024-03520-0","article-title":"Factors affecting rAAV titers during triple-plasmid transient transfection in HEK-293 cells","volume":"46","author":"Pistek","year":"2024","journal-title":"Biotechnol. Lett."},{"issue":"40","key":"10.1016\/j.critrevonc.2026.105521_bib98","doi-asserted-by":"crossref","first-page":"35675","DOI":"10.1021\/acsnano.5c11552","article-title":"Flower-Shaped Lipid Nanoparticles Evade Apolipoprotein E-Mediated Liver Tropism for Safe and Enhanced Cytokine-Based Cancer Immunotherapy","volume":"19","author":"Qi","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105521_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123717","article-title":"Reprogramming the glycocalyx: advances in glycoengineering for immunomodulation and regenerative medicine","volume":"326","author":"Rana","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10238-024-01490-1","article-title":"The crossroad between tumor and endothelial cells","volume":"24","author":"Ribatti","year":"2024","journal-title":"Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105521_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6122","key":"10.1016\/j.critrevonc.2026.105521_bib102","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \"Self\" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105521_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0514","article-title":"CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome","volume":"8","author":"Rodriguez-Marquez","year":"2022","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105521_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/biot.70135","article-title":"Optimizing Lentiviral Vector Production: Insights Into PiggyBac Transposase and Concatemeric Array Strategies","volume":"20","author":"R\u00f6scheise","year":"2025","journal-title":"Biotechnol. J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib105","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s42003-020-1052-8","article-title":"SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine","volume":"3","author":"Rothenburger","year":"2020","journal-title":"Commun. Biol."},{"issue":"6576","key":"10.1016\/j.critrevonc.2026.105521_bib106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib107","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105521_bib108","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.omtm.2020.04.016","article-title":"Vector Copy Distribution at a Single-Cell Level Enhances Analytical Characterization of Gene-Modified Cell Therapies","volume":"17","author":"Santeramo","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.critrevonc.2026.105521_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1248867","article-title":"The future of affordable cancer immunotherapy","volume":"14","author":"Schaft","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105521_bib110","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Sch\u00f6ttler","year":"2016","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib111","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","article-title":"Programmable multistage drug delivery to lymph nodes","volume":"15","author":"Schudel","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"33","key":"10.1016\/j.critrevonc.2026.105521_bib112","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303567120","article-title":"Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines","volume":"120","author":"Shepherd","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105521_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"issue":"Pt 2","key":"10.1016\/j.critrevonc.2026.105521_bib114","article-title":"vivo nano-engineering T cells for CAR-T therapy","volume":"388","author":"Shi","year":"2025","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17121520","article-title":"Rewiring T Cell Metabolism to Enhance CAR T Cell Function in Solid Tumor Microenvironments","volume":"17","author":"Song","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2026.105521_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114340","article-title":"Challenges in the analysis of pharmaceutical lentiviral vector products by orthogonal and complementary physical (nano)particle characterization techniques","volume":"200","author":"Stadler","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105521_bib117","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41590-023-01476-3","article-title":"Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control","volume":"24","author":"Swanson","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105521_bib118","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.omtm.2021.04.007","article-title":"The impact of lentiviral vector genome size and producer cell genomic to gag-pol mRNA ratios on packaging efficiency and titre","volume":"21","author":"Sweeney","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41408-024-01193-6","article-title":"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao","year":"2024","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s42003-025-07917-z","article-title":"KLHL25-ACLY module functions as a switch in the fate determination of the differentiation of iTreg\/Th17","volume":"8","author":"Tian","year":"2025","journal-title":"Commun. Biol."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105521_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/cells13231979","article-title":"Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile Mice","volume":"13","author":"Touramanidou","year":"2024","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105521_bib122","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkm440","article-title":"Nuclear accumulation of plasmid DNA can be enhanced by non-selective gating of the nuclear pore","volume":"35","author":"Vandenbroucke","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105521_bib123","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41571-021-00476-2","article-title":"Immunogenicity of CAR T cells in cancer therapy","volume":"18","author":"Wagner","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-024-01952-w","article-title":"Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105521_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2025.12.001","article-title":"CRISPR\/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming","author":"Wang","year":"2026","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105521_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104729","article-title":"Epigenetic landscapes drive CAR-T cell kinetics and fate decisions: Bridging persistence and resistance","volume":"211","author":"Wang","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105521_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/v15091801","article-title":"Innate immune response to viral vectors in gene therapy","volume":"15","author":"Wang","year":"2023","journal-title":"Viruses"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105521_bib128","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"Vivo CD19 CAR T-cell therapy for refractory systemic lupus erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105521_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658399","article-title":"Anti-AAV Antibodies in AAV gene therapy: current challenges and possible solutions","volume":"12","author":"Weber","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105521_bib130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/gt.2013.23","article-title":"Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction","volume":"20","author":"Witting","year":"2013","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13045-025-01759-2","article-title":"vivo CAR cell therapy: from bench to bedside","volume":"18","author":"Xu","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib132","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","article-title":"Intrinsic antiviral immunity","volume":"13","author":"Yan","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105521_bib133","article-title":"Current strategies for armoring chimeric antigen receptor T-cells to overcome barriers of the solid tumor microenvironment","volume":"16","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105521_bib134","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011807","article-title":"Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing","volume":"13","author":"Yu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105521_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172240","article-title":"Impact of physicochemical properties on biological effects of lipid nanoparticles: Are they completely safe","volume":"927","author":"Yuan","year":"2024","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.critrevonc.2026.105521_bib136","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: Facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib137","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105521_bib138","article-title":"Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering","author":"Zeng","year":"2026","journal-title":"bioRxiv"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105521_bib139","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/mt.2010.132","article-title":"A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors","volume":"18","author":"Zhang","year":"2010","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105521_bib140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00262-021-03009-z","article-title":"Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia","volume":"71","author":"Zhang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105521_bib141","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","article-title":"Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies","volume":"13","author":"Zheng","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105521_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111239","article-title":"The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDR","volume":"126","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"51","key":"10.1016\/j.critrevonc.2026.105521_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:48:44Z","timestamp":1793087324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":143,"alternative-id":["S1040842826004087"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105521","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cascading attrition of in vivo CAR-T therapy: From systemic delivery failure to functional collapse","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105521"}}